Sign in to view content

Assessing Characteristics of Patients With or Without Intraocular Inflammation (IOI) In the Brolucizumab Treatment Arms From the HAWK and HARRIER, Phase 3 Studies

Jeffrey S. Heier, MD

Video
Published 2020

Related

Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity
Rishi P. Singh, MD
Updates from the Field
2024
Ultra-Widefield Fluorescein Angiography and OCT Findings in Children and Young Adults With Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Arjun B Sood, MD
Annual Meeting Talks
2022
Commercial OCT Enters the Cellular Age – Tracking Macrophage Surveillance of the Macula Circulation!
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
Annual Meeting Talks
2021

Category: Age-Related Macular Degeneration

See more